Actavis is one of the world's leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. The successful integration of a number of acquisitions has helped position Actavis among the world’s largest companies in the industry. Founded in 1956, the Group has more than 10,000 employees operating in over 40 countries around the globe. Actavis’ headquarters are in Iceland.